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Abstract 
 
Myocardial hemorrhage (MH) may occur following myocardial infarction (MI). 
Myocardial hemorrhage can be assessed by image-based measurements of R2* (1/T2*) 
which are sensitive to iron-based byproducts of hemorrhage. However, automated 
detection of MH throughout the entire left ventricle (LV) is challenging due to R2* 
contributions from magnetic field distortions (susceptibility artifact). To provide insight 
for improved MH detection, we analyzed canine cardiac magnetic resonance images that 
had previously been acquired at baseline and several time points (3 to 41 days) following 
experimentally induced MI. The images were processed to generate R2* maps and cardiac 
polar plots. A baseline composite polar plot was generated to identify a large LV region (~ 
75% of LV) with relatively low and uniform R2* (suggesting low susceptibility artifact). 
The probability distribution of R2* values on the cumulative and individual polar plots was 
analyzed to provide insight for future development of automated analysis of MH.   Also, 
the boundaries of this uniform region were used to define the region over which post-MI 
polar plots were analyzed. A threshold (0.08 ms-1) to differentiate abnormally high R2* 
regions from normal R2* regions was determined from baseline polar plots. The mean R2* 
values of normal regions in the post-MI images remained approximately constant as a 
function of time post-MI and close to the mean R2* from baseline images. The mean R2* 
values of abnormal regions appeared to peak at day 3 post-MI but remained elevated 
compared to the remote region (0.04 ms-1): day 3 (0.11 ms-1, p < 0.001), day 7, 15, 21 and 
41 (0.08 ms-1, p < 0.05). At all post-MI times investigated, these data suggest that 
hemorrhage and its byproducts remained for several weeks.  
 
 
Keywords 
Myocardial hemorrhage, Left ventricle, Myocardial infarction, Probability distribution. 
 
ii 
 
 
 
Acknowledgments 
 
 
First, I am grateful for my God (Allah) for everything in my life. Who does not thank 
God does not thank people.  I would love to express my faithful thanks to my thesis 
supervisors, Dr. Donna Goldhawk, and Dr. Neil Gelman. The doors to Dr. Goldhawk and 
Dr. Gelman offices were always open whenever I faced trouble in my research or writing. 
They consistently steered me in the right path whenever they thought I needed it. 
I would also like to thank my committee advisors, Dr. Frank Prato, and Dr. Jonathan 
Thiessen, for their advice and insightful comments regarding my work.  Also, I am 
grateful to Dr. Terry Thompson for being our lab's collaborator. My sincere gratitude also 
goes to the Goldhawk lab's members for their help with my study. Specifically, I would 
like to thank Daisy Sun, Sarah Donnelly, and Tian Hou and Praveen Dassanayake. 
Special thanks for my colleague Farzad Asadi for his help.  I would also like to 
acknowledge Heather Biernaski and John Butler, for their technical assistance during this 
project.  
Last but not least, I would like to thank my family. First is a special thanks to my wife, 
Areej Al-Saad, who always encouraged me to move forward in my education and career.  
Also, I am so grateful to my own family especially my children, Lammar, Hamzah, 
Mohammad, and my lovely Miayar. I would also like to thank my extended family 
members, in particular, my mother, for her all prayers for me, my sisters and brothers. 
God bless my father.   
 
 
 
 
 
iii 
 
 
 
 
 
Table of Contents 
 
 
 
Abstract ................................................................................................................................ i 
Acknowledgments............................................................................................................... ii 
Table of Contents ............................................................................................................... iii 
List of Abbreviations .......................................................................................................... v 
List of Figures .................................................................................................................... vi 
List of Tables .................................................................................................................... vii 
Chapter 1: Introduction ....................................................................................................... 1 
1 Introduction ................................................................................................................. 1 
1.1 The heart ............................................................................................................... 2 
1.2 Myocardial infarction ........................................................................................... 5 
1.2.1 Pathophysiology of MI ................................................................................. 6 
1.2.2 Pathophysiological responses post-MI ......................................................... 6 
1.3 Utilization of cardiac MRI in myocardial hemorrhage ........................................ 8 
1.3.1 Basic concepts of MRI .................................................................................. 8 
1.3.2 Myocardial Hemorrhage Imaging ............................................................... 14 
1.3.3 Cardiac multi-echo GRE sequence for T2* measurement .......................... 15 
1.4 17-Segmentation LV model: the polar plot map ................................................ 17 
1.5 Graphical Techniques: The Probability Plot ...................................................... 19 
1.6 Overview of the thesis ........................................................................................ 21 
Chapter 2: Methods ........................................................................................................... 24 
2 Background ................................................................................................................ 24 
2.1 Methods .............................................................................................................. 26 
2.1.1 CMR acquisition of baseline images .......................................................... 26 
iv 
 
2.1.2 CMR acquisition of post-MI images .......................................................... 26 
2.1.3 CMR acquisition of healthy volunteers ...................................................... 27 
2.1.4 Myocardial R2* calculation and R2* map construction ............................. 27 
2.1.5 R2* Precision and Goodness of Fit ............................................................. 28 
2.1.6 Fitting MRI signal to region of interest ...................................................... 29 
2.1.7 Bulls-eye map construction......................................................................... 29 
2.1.8 Probability Plot Method .............................................................................. 31 
2.1.9 Analysis of R2* images .............................................................................. 33 
2.1.10 Statistical analysis ....................................................................................... 33 
Chapter 3: Results ............................................................................................................. 35 
3 Results ....................................................................................................................... 35 
3.1 The signal decay model ...................................................................................... 35 
3.2 Effect of number of images on R2* measurements ........................................... 35 
3.3 Healthy volunteer R2* measurements................................................................ 37 
3.4 Spatial variation of R2* at baseline.................................................................... 38 
3.5 R2* segmental analysis at baseline .................................................................... 39 
3.6 Signal decay model for post-MI images ............................................................ 43 
3.7 R2* Analysis for images post-MI ...................................................................... 45 
Chapter 4: Discussion, Summary and Future Work ......................................................... 50 
4 Discussion .................................................................................................................. 50 
4.1 Summary ............................................................................................................ 56 
4.2 Future Work ....................................................................................................... 58 
4.3 Conclusion:......................................................................................................... 60 
References………………………………………………………………………….….61 
   Appendix………………….…………………………….…………………………......77 
 
 
 
 
 
 
v 
 
 
 
List of Abbreviations 
 
AAR Area At Risk 
 
AHA American Heart Association 
 
CMR 
 
Cardiac Magnetic Resonance 
ECG   Electrocardiogram 
 
GRE   Gradient Echo 
 
LA   Left Atrium 
 
LAD Left Anterior Descending Artery 
 
LCA   Left Coronary Artery 
 
LCX   Left Circumflex Artery 
 
LV 
 
Left Ventricle 
MI Myocardial Infarction 
 
RA Right Atrium 
 
RCA 
 
Right Coronary Artery 
 
RV 
 
Right Ventricle 
 
SD 
 
Standard Deviation 
SI 
 
Signal Intensity 
 
SNR 
 
Signal-to-Noise Ratio 
 
TE 
 
Echo Time 
 
TR 
 
Repetition Time 
 
T2*W 
 
T2* weighted image 
vi 
 
 
 
 
List of Figures 
 
Figure 1. 1. Anatomy of the heart. ...................................................................................... 3 
Figure 1. 2. Coronary arteries. ............................................................................................ 4 
Figure 1. 3. Larmor frequency. ........................................................................................... 9 
Figure 1. 4. Gradient echo image pulse sequence diagram............................................... 13 
Figure 1. 5. ECG-triggered GRE sequence schematic.. .................................................... 16 
Figure 1. 6. Drawing of the 17-segment LV model. ......................................................... 18 
Figure 1. 7. Probability plot test for random data.. ........................................................... 20 
Figure 2. 1. Radial sampling of the myocardial R2* map.. .............................................. 30 
Figure 2. 2. Threshold determination technique. Data were tested using the probability 
plot method. ...................................................................................................................... 32 
Figure 3. 1. A mono-exponential decay model ................................................................. 35 
Figure 3. 2. The influence of number of echoes on R2*, STE, and 1 ‒ r2 maps ............... 36 
Figure 3. 3. Baseline R2* relaxation rates. ....................................................................... 38 
Figure 3. 4. Segmental analysis of the composite baseline polar plot for R2*. ................ 40 
Figure 3. 5. R2* distribution in the region of the LV denoted as a baseline signal .......... 41 
Figure 3. 6. Baseline R2* relaxation rates and their distribution.. .................................... 42 
Figure 3. 7. Pattern of signal intensity decay post-MI. ..................................................... 44 
Figure 3. 8. R2* maps of the entire LV post-MI .............................................................. 45 
Figure 3. 9. Automatic delineation of the abnormally high R2* region ........................... 46 
Figure 3. 10. Comparison of the abnormally high R2* region based on the reported and 
proposed thresholds .......................................................................................................... 47 
Figure 3. 11. Analysis of the abnormally high R2* region post-MI…………………......49 
 
 
vii 
 
 
 
 
List of Tables 
 
 
Table 1. Mean R2*, STE and 1 ‒ r2 for the entire LV relative to the number of echoes / 
slice used for  generating R2* maps. ................................................................................ 37 
Table 2. Mean R2* values for different slice thicknesses, standard deviation (SD) and 
difference  in R2* between 6 mm and 4 mm slice thickness values................................. 37 
Table 3. Comparison of baseline %CV and thresholds based on the 95 percentile.......... 43 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Chapter 1: Introduction 
1         Introduction 
Myocardial infarction (MI) is a common manifestation of heart disease and mortality. In 
2012-13, approximately 2.4 million Canadian adults aged 20 years or older were diagnosed 
with heart disease, including 578,000 with a history of MI [1]. 
Occlusion of one or several of the heart’s coronary arteries may cause MI and one of the 
pathophysiological complications occurring post-MI is myocardial hemorrhage. However, 
since its identification in the early 1960s, the pathophysiology of myocardial hemorrhage 
is still unclear. A large amount of hemorrhage can lead to severe inflammation and 
influence the healing process. Detection of myocardial hemorrhage using noninvasive 
methods such as magnetic resonance imaging (MRI) would be beneficial for precise risk 
stratification and potential therapeutic strategies.  
Assessment of the myocardial T2* relaxation rate has been shown to add relevant 
information. Signal below the normal range of myocardial T2* (<20 ms) is  associated with 
a significant decrease in left ventricle (LV) ejection fraction [2]. However, a reliable 
assessment of myocardial T2*-weighted images of the entire LV post-MI is challenging 
due to image artifacts and the presence of edema. In addition,  manual delineation of the 
hypointense zone is prone to observer errors [3]. Furthermore, myocardial T2* mapping 
post-MI in most previous studies was performed at 1.5 Tesla (T); whereas, conceptually, 
myocardial mapping at 3 T is interesting due to improved signal at higher field strength 
which contributes enhanced signal to noise ratio (SNR). Also, the relaxation rate 1/T2* 
associated with iron-related contrast (such as hemorrhage) increases with field strength. In 
this thesis, we examined myocardial T2* at 3 T in a canine MI model using a T2* mapping 
technique. The studies include animals with no injury and animals studied at various time 
points (3 to 41 days) post MI.  
In this thesis chapter, we will provide an introduction to the heart and the pathophysiology 
of MI, including a discussion on myocardial hemorrhage, utilization of cardiac magnetic 
resonance (CMR) in myocardial hemorrhage, and state-of-the-art mapping methods. 
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1.1        The heart 
The  long axis of the heart in the body is oriented obliquely relative to the long axis of the 
body. The superior portion of the heart is called the base, which is connected to the vena 
cava, aorta, pulmonary arteries and veins. The inferior part of the heart, located above the 
diaphragm, is called the apex. 
The heart comprises four chambers: the upper chambers are the right atrium (RA) and left 
atrium (LA); the lower chambers are the right ventricle (RV) and left ventricle (LV) (Figure 
1.1). The right and left side of the heart work synchronously. Blood enters the right side of 
the heart and is sent to the lungs. Oxygenated blood is passed to the left side of the heart 
and pumped out to the body. In humans, the heartbeat ranges from 60 to 100 beats per 
minute, at rest. Adequate and stable circulation of blood is ensured by the myocardium and 
may be affected by injuries, such as MI, that cause abnormal cardiac function.   
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Figure 1. 1. Anatomy of the heart. The diagram indicates the four chambers of the heart; 
left atrium (LA), left ventricle (LV), right atrium (RA), and right ventricle (RV). The 
oxygen-poor blood flows from the RA to the RV through the tricuspid valve (blue arrows). 
The oxygen-rich blood flows from the LA to the LV through the mitral valve (red arrow). 
The wall of the heart includes three layers: Epicardium, Myocardium, and Endocardium. 
The diagram was extracted from the Texas Heart Institute website with permission from 
Texas Heart Institute [4]. 
Cells of the heart tissue may be grouped into two major categories: myocytes and non-
myocytes. Myocytes form ~70-80% of the myocardial volume. Non-myocytes include 
immune cells, endothelial cells, and fibroblasts. All components of the heart participate in 
cardiac function and seem to be involved in the response to myocardial injury. While 
myocytes are the main contributors to contractile activity, they may also play a central role 
in cardiac dysfunction [5, 6].  
As a circulatory pump, the heart gets its nutrients from the coronary arteries. There are four 
major coronary arteries:  the left coronary artery (LCA) and the right coronary artery 
(RCA). The LCA is divided into two branches: the circumflex artery (LCX) which supplies 
blood to the lateral and back side of the LV, and the left anterior descending artery (LAD) 
which supplies the frontal side of the septum in addition to the bottom and front side of the 
LV. The RCA supplies the right ventricle (Figure 1.2). Disorders of the coronary arteries 
have severe implications because they limit the blood supply to the heart, causing 
myocardial ischemia and necrosis. In severe cases, the myocardial infarction may then 
evolve to heart failure.  
The canine heart has a well-developed system of collateral vessels which is an important 
similarity to the human heart. However, there are several species differences. A canine 
heart has various pulmonary veins, varying from 4 to 8 while the human heart has only 4 
or 5 pulmonary veins. At rest, an adult dog's heartbeat ranges from 60 to 160 beats per 
minute, varying more widely compared to the human heart rate (60-100 beats per minute). 
Additional differences involve the positioning of the vena cava and slight variations in the 
shapes and sizes of the atrial appendages [7, 8]. 
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Figure 1. 2. Coronary arteries of the heart. The diagram indicates the four coronary 
arteries: :  left anterior descending (LAD), left circumflex (LCX), left coronary artery 
(LCA), and right coronary artery (RCA). The diagram was extracted from the Texas Heart 
Institute website with permission from Texas Heart Institute [9].  
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1.2        Myocardial infarction 
Myocardial infarction can be classified based on anatomical and clinical diagnostic criteria. 
From an anatomic point of view, MI is categorized as either transmural or nontransmural. 
A transmural MI, also called a full-wall thickness MI, results in ischemic necrosis 
extending from the endocardium (inner wall) through the myocardium to the epicardium 
(outer wall) of the LV (Figure 1.1). A nontransmural MI corresponds to ischemic necrosis 
that does not spread through the full thickness of the myocardium. The least perfused zones 
of the heart, which are at the highest risk of ischemia, are the endocardial and 
subendocardial regions [10]. 
Clinically, an electrocardiogram (ECG) is used to monitor electrical variations in the heart. 
At rest, cardiac cells are polarized, resulting in a difference in electrical potential across 
their membranes. When they depolarize, the ECG records the sequence of waves that 
correlate with electrical impulses during each heartbeat. In a normal recording, the waves 
are labeled P, Q, R, S, and T. The P wave represents atrial depolarization. During this 
process, the two atria are contracting. The QRS wave represents ventricular depolarization, 
causing ventricular contraction. Atrial repolarization and relaxation take place after the P 
wave and is found within the QRS complex because ventricles tend to contract more 
strongly than atria. The T wave represents ventricular repolarization when the ventricles 
are relaxing. Changes in the waveforms and distances among the waves can be used 
clinically to estimate the severity of MI. For example, based on electrocardiographic 
findings, an ST-elevation myocardial infarction (STEMI) is caused by sudden complete 
blockage of a coronary artery (LAD or RCA). A severely narrowed artery which is not 
completely blocked usually creates a non-ST-elevation myocardial infarction (NSTEMI). 
However, this classification does not distinguish transmural from nontransmural MI [11]. 
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1.2.1    Pathophysiology of MI 
The primary cause of MI is a build-up of atherosclerotic plaque(s) in the coronary artery. 
A rupture in the plaque forms a thrombus which in turn reduces the flow of blood to the 
heart muscle, causing ischemia. This creates a partial or complete decrease in oxygen to 
the area depending on that vascular supply and also necrosis, which is the death of 
myocardial cells or tissue [12]. In animal studies, MI can be created by direct occlusion of 
either the LAD or LCX by ligation of the artery. Studies in a canine MI model showed that 
the evolution of cell death (myocyte necrosis) with time progressed as a wave front, starting 
at the endocardium and extending to the epicardium. The area at risk (AAR) is defined as 
the myocardial area distal from the occlusion distal from the occlusion [13]. The 
experimental model used in this thesis is described in section 2.1.2. 
Experimentally, the minimum time for inducing a small MI is in the range of 20-30 
minutes. The relationship between infarct size and duration of the occlusion is not linear 
[14]. Studies have compared 40 versus 90 minutes of coronary artery occlusion, which 
produced infarct sizes of 16% and 32%, respectively, while 24 hours of occlusion induced 
an infarct size involving 45% of the AAR [15, 16]. Furthermore, small deviations in the 
position of the coronary artery occlusion can lead to large differences in the infarct size. 
While studying MI in anesthetized animals failed to prove that infarct size was affected by 
myocardial demand, infarct size was related to myocardial demand in the conscious state 
[17–19]. 
 
1.2.2   Pathophysiological responses post-MI 
Restoration of coronary artery perfusion to the ischemic myocardial region is the most 
critical process for limiting ventricular arrhythmias, infarct size and risk of heart failure 
[20]. However, reperfusion injury may be an adverse outcome of the process since it has 
been correlated with worsening or progression of ischemic damage. This leads to apoptosis 
and stunning (brief cardiac dysfunction due to ischemia) as well as reperfusion 
arrhythmias, and irreversible injury [21].  
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Edema is also associated with ischemia-reperfusion in MI and occurs because of an 
inflammatory reaction. Endothelial leakiness causes swelling of tissue and results in 
excessive fluid, plasma protein leakage and changes in osmotic pressure in the ischemic 
region [22]. Microvascular obstruction (MVO), also referred to as a no-reflow 
phenomenon, results from blockage of the myocardial microcirculation (in vessels less than 
200 μm in diameter). MVO is associated with poor patient outcome and adverse left 
ventricular remodeling [23]. Furthermore, severe microvascular injury coupled with 
reperfusion may result in myocardial hemorrhage, defined as the extravasation of 
erythrocytes (red blood cells) through severely damaged endothelial walls [24]. 
Myocardial hemorrhage is associated with left ventricular systolic dysfunction [25], 
adverse remodeling representing changes in the heart size and function [26, 27] and poor 
clinical outcomes [28]. 
The histological findings of early studies by Kolner et al. [29], in a canine MI model, 
showed that myocardial hemorrhage was located in the core of the infarcted region. 
Subsequent experimental analyses have presented additional insight into the 
pathophysiology of endothelial injury and myocardial hemorrhage. Through coronary 
artery occlusion, the cardiovascular endothelium undergoes hypoxia and high shear stress. 
The hypoxic environment promotes the production of cytokines and growth factors which 
influence vascular leakage and increase vascular permeability. As a result, the endothelial 
wall becomes vulnerable and eventually necrotic [30–32]. 
Despite the increased risk of myocardial hemorrhage with continued periods of ischemia, 
this condition, apart from reperfusion, does not lead to myocardial hemorrhage. Occlusion 
alone will cause intracellular swelling of the endothelial cells and myocytes, while 
reperfusion is attributed with inducing myocardial hemorrhage [33, 34]. During the 
extravasation of red blood cells from the endothelium into the myocardium, edema forms 
and restricts the healing process [35]. However, Kali et al. (2016) [36] showed that iron 
deposition appeared in permanent occlusion MI (non-reperfused). 
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1.3 Utilization of cardiac MRI in myocardial hemorrhage 
Cardiovascular magnetic resonance (CMR) imaging has achieved clinical importance in 
the noninvasive evaluation of myocardial viability and function post-MI, allowing for high- 
resolution assessment of the infarct size. A hypointense core within the infarcted 
myocardium in T2-weighted and T2*-weighted CMR has been correlated with the presence 
of hemorrhagic infarcts [37, 38]. The breakdown products of hemoglobin are paramagnetic 
substances and hence contribute to shortening of T2* relaxation times. Thus, CMR is 
considered a powerful technique for post-MI assessments. Its growing use in clinical care 
assists clinicians to establish an accurate diagnosis and aides in therapeutic decision 
making. 
1.3.1 Basic concepts of MRI 
The MRI signal utilized to produce images is either from water or fat within the tissue. 
Certain nuclear species including the hydrogen nucleus have a property known as nuclear 
spin (S). These nuclei also have an associated magnetic moment (μ) due to a spinning 
charge (e.g., proton) which is related to the spin by 
                                              μ =  S                                (1.1) 
where  is known as the gyromagnetic ratio. Normally, the magnetic moment vectors are 
orientated randomly. To detect the MRI signal, these nuclei are subjected to a static 
magnetic field (B0), where the direction of B0 defines the direction of the z-axis of the 
coordinate system used in MRI. In this situation, the z-components of magnetic moments 
(μ) of the nuclei will either align parallel (low energy state) or anti-parallel (high energy 
state) to the direction of B0.   This realignment occurs over a time period of several times 
longer than the T1 relaxation time (defined below) which is typically of the order of a few 
to several seconds. A greater proportion of these magnetic moments aligns parallel to B0 
than antiparallel, leading to a net proton nuclear magnetization vector (M0) in the direction 
of B0 where the proton nuclear magnetization is the vector sum of all proton magnetic 
moments per unit volume. Also, the magnetic moments precess around the direction of B0 
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(Figure 1.3), with an angular frequency known as the Larmor frequency (ω0) and described 
by  
                                                 ω0 = γ B0                                                              (1.2) 
where γ is the gyromagnetic ratio of the nucleus (γ/2π = 42.58 MHz/T for hydrogen 
(1H)), and B0 is the primary magnetic field in Tesla (T).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 3. Larmor frequency. The rotation of the axis of spin (blue dashed arrow) of 
the nucleus around the direction of B0 is called precession. The small red arrow 
designates the nuclear spin and the precession is designated by the small black arrow.  
B
0
 
μ 
Proton 
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The frequency of precession is called Larmor frequency and depends on the strength of 
B0. 
 
When a time-dependent magnetic field (B1) in the form of a short pulse is applied at ω0, it 
results in a disturbance of the spin alignment. Some low energy parallel spins flip to high 
energy states, decreasing longitudinal magnetization. As a result, the net magnetization 
vector (M0) turns towards the transverse plane (perpendicular to B0), producing a 
transverse magnetization (Mxy). 
When B1 is switched off, a portion of the protons flips back to the low energy state, losing 
their kinetic energy to the surrounding nuclei. until thermal equilibrium is achieved and the 
magnetization returns its initial value parallel to B0. This process is known as longitudinal 
relaxation or spin-lattice relaxation. The longitudinal relaxation time (T1) is the time 
required for Mz to reach 63% of its equilibrium value (M0).  
                                                       Mz (t) = M0 (1-e
-t/T1)                                  (1.3) 
The equation above assumes that Mz = 0 at t =0. Variations in T1 among tissues is utilized 
to generate signal contrast on MR images.  
Proton magnetic moments that were in phase start to dephase due to the variation of the 
Larmor frequency between nuclei. This is called spin-spin relaxation and results in a 
reduction in Mxy according to 
                                                       Mxy = M0 e-t/T2                                            (1.4) 
where T2 is the time required for Mxy to decay to approximately 37% of its initial value. 
Transverse relaxation happens more quickly than longitudinal relaxation and is due to 
mechanisms related to the dephasing process among spins. Spatial variations in the 
magnetic field experienced by protons cause spatial variation in ω0 throughout the tissue. 
On a microscopic scale, the random spatial variations are generated by the presence of 
adjacent nuclei, which generate weak magnetic fields. Also, dephasing occurs due to the 
exchange of energy between nuclei. These processes result in T2 relaxation. 
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On a macroscopic scale, even if the applied B0 is considered perfectly homogeneous, 
variations in magnetic susceptibilities of various biological materials create spatial 
variation in the magnetic field experienced by protons. Paramagnetic (or 
superparamagnetic) particles, like iron-containing byproducts of hemorrhage, have 
positive susceptibility and generate substantial variation in the magnetic field. Other 
biological substances, such as hemoglobin in red blood cells and ferritin in tissue, are 
paramagnetic and accelerate spin dephasing.  
The majority of biological substances are diamagnetic. The variations in diamagnetism at 
air-tissue interfaces leads to distortion of the magnetic field. These air-tissue interferences 
are associated with the heart-lung interface and air pockets in the colon, bowel, and 
stomach. This leads to macroscopic variation in the magnetic field which contributes to 
T2* and is known as a (magnetic) susceptibility artifact or susceptibility effect. The 
relaxation rate due to the static component of magnetic field inhomogeneities is denoted 
1/T2ʹ. 
 
T2* represents the combination of T2 relaxation time and T2ʹ relaxation time, due to field 
inhomogeneities, and can be expressed as 
                                                 1/T2* = 1/T2 + 1/T2ʹ                                     (1.5) 
assuming that T2´ decay is exponential. The transverse relaxation attenuates exponentially 
after the radio frequency (RF) excitation and is defined as the free induction decay (FID). 
The relaxation time constants (T2, T2* and T2ʹ) can be expressed as relaxation rates 
defined by R2 =1/T2, R2* =1/T2* and R2ʹ =1/T2ʹ.  
The MR signals generated above can be localized and encoded using magnetic field 
gradients that vary linearly with position inside the magnet and cause variation in ω0 as a 
function of position. Gradient coils generating these linearly varying magnetic fields are 
located within the bore of the primary magnet [39]. Three steps are used to produce two-
dimensional (2D) MR images by applying a combination of RF and gradient magnetic 
fields; slice selection, spatial encoding, and frequency encoding. To excite protons within 
the desired slice, a one-dimensional slice-selection gradient and RF pulse are applied 
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simultaneously. This gradient field causes a linear change of resonance frequencies as a 
function of position.  The RF pulse frequency matches the frequency included in the 
selected slice. The direction of the selected gradient determines the orientation of the slice. 
Instead of a single frequency, the excitation RF pulse is composed of a range of 
frequencies, identified as the RF transmit bandwidth. RF bandwidth and the strength of the 
gradient determine the slice thickness. 
Spatial encoding within the slice can be achieved by using two techniques, frequency 
encoding and phase encoding, applied in an orthogonal direction with respect to each other. 
In frequency encoding, the magnetic field gradient is applied throughout signal acquisition. 
The location of the spins along the direction of the gradient can be recognized by the 
frequency of their emitted signals. In traditional 2D MRI, frequency encoding is not 
adequate by itself because it gives positional information only in one direction. Therefore, 
a phase encoding gradient field is applied as a short pulse before data acquisition, providing 
a phase distribution among the spins. To obtain position information from the phase, the 
process is repeated several times with phase encoding gradients of incrementally different 
amplitudes. The output data are recorded as a set of lines in a 2D signal array within a 
domain identified as K-space. Applying 2D Fourier transform to K-space data recovers the 
spatial distribution of the signal, an operation known as image reconstruction [40]. 
In general, the gradient echo sequence (GRE) is a manipulation of the FID signal. It starts 
by applying an RF pulse and slice-selective gradient (Gz) simultaneously. Shortly after 
that, a gradient (Gy) is applied in the phase encoding direction, followed by an external 
dephasing gradient field (Gx) across the tissue. These gradients cause a variation in local 
magnetic fields and consequently changes the resonance frequencies across the specimen. 
Dephasing of the FID is accelerated. Then the process is reversed, and a second gradient 
magnetic field is applied with opposite polarity to the dephasing gradient. The spins begin 
to re-phase until they are again in phase and a signal is generated. This single echo gradient 
echo sequence is shown in Fig 1.4. The same process can be repeated to produce multiple 
GREs after a single RF-pulse (see Fig 1.5.  for a cardiac multiple GRE sequence.).   
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Figure 1. 4. Gradient echo image pulse sequence diagram. A simple pulse sequence 
implements slice-selection and within slice spatial encoding. The top line depicts the RF 
pulses, which rotates the magnetization toward the xy plane. The lines listed as Gz, Gy, 
and Gx designate the magnetic field gradient in slice-select, phase-encoding, and 
frequency-encoding directions, respectively. The analog to digital converter (ADC) is 
applied during signal acquisition [41]. 
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1.3.2       Myocardial Hemorrhage Imaging  
At the early stages of myocardial hemorrhage, it is difficult to visualize small quantities of 
red blood cells. Nevertheless, the specificity of MRI for detecting hemorrhage has been 
validated in vivo [42, 43]. 
 Histopathological analysis has verified the potential of MRI sequences (based on T1-, T2- 
and T2*-weighted images) to diagnose myocardial hemorrhage [44, 45]. In particular, T2*-
weighted imaging is currently the standard clinical method for diagnosing myocardial 
hemorrhage [34, 45]. Along with degradation of red blood cells, hemoglobin is broken 
down into several products (oxyhemoglobin, deoxyhemoglobin, methemoglobin, 
and hemosiderin) which influence MRI signal intensities. These vary based on electronic 
configuration of various hemoglobin by-products, with number of unpaired electrons (N) 
having the greatest influence on the MR signal [46, 47]. Deoxyhemoglobin and 
methemoglobin are best detected by T2- and T1-weighted sequences, respectively [48]. In 
addition, since lysis of red blood cells also releases ferritin and hemosiderin, iron 
deposition from multiple sources can be detected by T2- or T2*-weighted imaging  [49]. 
While the observation of myocardial hemorrhage has prognostic value beyond that 
provided by the observation of microvascular obstruction alone, the relationship between 
myocardial hemorrhage and microvascular obstruction remains unclear. In addition, the 
effect of myocardial edema may limit the delineation of hemorrhage and, in the case of 
severe edema, hemorrhagic regions may be enormously underestimated [49, 50].  
 Despite these complications, CMR imaging using T2 and T2* shortening has improved 
the assessment of myocardial hemorrhage, owing to the elevated tissue density of 
paramagnetic hemoglobin breakdown products. Early studies by Lotan et al. [51, 52] 
illustrated T2* shortening concurrent with hemorrhage at 24 and 72 hours post-reperfusion 
in canine MI.  
T2* mapping has subsequently been used in several patient and animal studies on 
myocardial infarction. These studies indicate that T2* mapping provides greater accuracy 
than T2 mapping in differentiating between hemorrhagic myocardium and healthy regions 
remote from the injury, and reduces the effect of myocardial edema [53]. We also note that 
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several studies have described a linear increase in rate of signal decay (R2* = 1/T2*) with 
hepatic iron level [54–60]. (This linear relation of R2* with iron is one reason that an R2* 
map may be more convenient than a T2* map.) Similar variations in R2* have been 
qualitatively correlated with cardiac iron deposition [61]. Myocardial hemorrhage is 
marked as a region of reduced signal intensity, in animal MI models and humans within 
the infarcted area on R2* maps, with R2* > 0.05 ms-1 [38, 53, 62, 63]. This threshold value 
for R2* was initially determined at 1.5 T but has been validated at 3 T. Some researchers 
have even suggested that the difference between R2 and R2*, called R2′, may be a more 
precise marker of tissue iron [64]. In a canine model of myocardial hemorrhage [65],  the 
sensitivity and specificity of T2 imaging were found to be 98% (94–100%) and 90% (83–
98%), for detection of the myocardial hemorrhage, respectively. For T2* the sensitivity 
and specificity were 95% (86–100%) and 94% (88–100%), respectively. 
 
1.3.3 Cardiac multi-echo GRE sequence for T2* measurement 
Here we briefly describe the CMR sequence used in this thesis for T2* mapping (Siemens 
WIP #44B.1, VB20P). With this sequence, the MRI signals are collected over multiple 
heartbeats. To achieve synchronization between the pulse sequence and signal acquisition 
during the cardiac cycle, ECG triggering is used. Also, the respiratory motion must be 
considered because it causes image degradation. This can be reduced using several 
approaches, such as acquisition during a breath hold and respiratory gating. Breath-hold 
was applied in the images analyzed for this thesis. 
 Figure 1.5 demonstrates the acquisition process starting after each ECG wave. Data are 
obtained through the T2* decay. Triggering is applied to acquire relatively static images at 
a certain time in the cardiac cycle. Typically, signals required to reconstruct a single T2* 
map are obtained at the same heart phase (in diastole) over multiple heartbeats. 
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Figure 1. 5. ECG-triggered GRE sequence schematic. Signals are obtained following a 
predefined delay after the ECGR-wave. In the present work, eight echoes were collected 
in every repetition time (TR) to produce eight T2*-weighted (T2*W) images. Nine to ten 
k-space lines were obtained in each cardiac cycle. Echo times ranged from 3 to 23 ms. This 
figure is reproduced with permission from Siemens Health Care and Sven Zuehlsdorff 
(Siemens Health Care). 
 
For so-called black blood images, the blood pool signal is suppressed using two additional 
180° RF inversion pulses. The first pulse inverts the magnetization of the entire volume of 
blood and tissue within the RF coil (i.e., nonselective). The second inversion pulse returns 
the magnetization of the desired slice to be imaged. The resultant effect of these two pulses 
is to return the magnetization within the slice to its state before applying the first RF 
excitation pulse and to invert the magnetization of tissue and blood outside the slice. The 
blood streaming into the slice will have a dark signal, since blood has left the slice by the 
time the second inversion pulse is applied. Thus, the acquired images provide a distinct 
boundary between chamber and myocardium 
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1.4   17-Segmentation LV model: the polar plot map 
In 2002, The American Heart Association (AHA) introduced a 17-segment model, 
providing regional analysis of the LV [66]. This 17-segment model is applied for imaging 
slices in the short axis orentation. To consider anatomical variations in the LV that result 
from patient to patient variability, several cardiac imaging modalities have been used to 
achieve a consensus for regional analysis of the LV, including computed tomography (CT), 
coronary angiography, positron emission tomography (PET), single-photon emission 
computed tomography (SPECT), and MRI [67, 68]. In this bulls-eye map, quantitative data 
generated from these imaging modalities have been used to create a polar plot based on the 
standard 17-segment model [69, 70]. These polar plots from tomographic images of the 
LV have been employed for regional analysis of cardiac function, like wall thickening or 
myocardial perfusion. 
The plots consist of three concentric rings, stacked together as shown in Figure 1.6 A. Each 
ring represents a short-axis view through the LV. The first (outer) ring corresponds to the 
basal region of the heart, the second ring represents the mid-cavity, and the third (and 
smallest) ring is at the apex of the heart. The center of the polar plot outlines the apical cap 
where the cavity ends. Both basal and mid-cavity rings are arranged into six portions 
numbered 1−6 and 7−12, respectively. The numbers start anteriorly and continue 
counterclockwise around the ring. The apical ring is partitioned into only four segments 
numbered 13−16 due to its smaller size. The apical cap is indicated by one segment (17 in 
Figure 1.6A). The distribution of myocardial mass within the basal, mid-cavity, and apical 
segments is 35%, 35%, and 30%, respectively. Different myocardial segments have been 
assigned to the main coronary arteries (RCA, LAD, and LCX in Figure 1.6 B). 
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Figure 1. 6. Drawing of the 17-segment LV model. (A) The 17 segments of the polar 
plot are shown, with the nomenclature identifying anatomical regions of the tomographic 
image. Numbered segments begin at the base of the LV and progress toward the apex. 
(B) While the main coronary arteries supply different regions of the LV, each ring is 
affected by all three of the major arteries. The LAD generally serves the apex (17) and 
anteroseptal regions (1-2, 7-8 and 13-14); the RCA generally serves the inferoseptal 
regions (3-4, 9-10 and 15); and the LCX generally serves the lateral regions (5-6, 11-12 
and 16) [71].   
(A) 
(B) 
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1.5  Graphical Techniques: The Probability Plot 
Many graphical methods such as a histogram or a stem plot can be used to reveal non-
normal features of a distribution, for example, outliers, skewness, and clusters [72]. These 
features provide an indication of the appropriate distribution model for the data. The 
probability plot is a graphical method for assessing whether or not data exhibit a standard 
normal distribution (i.e. a Gaussian distribution). For a given distribution of (n) data points, 
the data can be ordered from smallest, which is called the first order statistic to the largest. 
The probability (percentile) value which is defined as the order statistic medians for the 
given distribution (Ui) is described by [73]: 
                                               Ui = 1 - Un    for i = 1                                                        (1.6)                          
                                               Ui = (i - 0.3175)/(n + 0.365)    for i = 2, 3, ..., n-1 ,              (1.7) 
                                               Ui = 0.5
(1/n)    for i = n                  .                                        (1.8) 
For a given data distribution, the probability plot is created by plotting the actual data 
against the probability (percentile) that individual value occupies. The pair points (actual 
data, probability) can be fitted to a line that is designated as a reference line, which 
represents a theoretical normal distribution. Deviation from the straight reference line 
indicates deviation from normality [74] (Figure 1.7). 
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Figure 1. 7. Probability plot test for random data. The graph shows theoretical data to 
illustrate where the points deviate from the theoretical straight line (blue) and follow a 
non-Gaussian distribution. 
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1.6             Overview of the thesis 
CMR has achieved clinical importance in the noninvasive evaluation of myocardial 
viability and function post-MI, allowing for high-resolution assessment of AAR, infarct 
size, and MVO. These in turn are strong predictors of myocardial hemorrhage which often 
happens following MI [75]. Hemorrhage indicates the extravasation and accumulation of 
red blood cells in cardiac tissue and is a demonstration of acute microvascular injury [43, 
76, 77] . The MI also leads to inflammation and this too influences the healing process 
[78]. Responses post-MI also affect the detection of myocardial hemorrhage. For example, 
the region of MVO may considerably overlap with the area of hemorrhage [43] and in the 
presence of edema, the hemorrhagic zone may be greatly minimized [3].  
Despite these confounders, the specificity of MRI for detecting hemorrhage has been 
validated in several experimental studies [79–81]. Visualization of hemorrhage is 
attributed to the degradation of erythrocytes, which leads to iron deposition that can be 
detected on T2*-weighted MR images [3, 45]. In one of the currently accepted approaches 
for differentiating between hemorrhagic and remote tissue, manual delineation of the 
remote tissue is based on the late gadolinium-enhanced MR images of the region that 
manifests no hyperintensity. This region is used as a reference on T2*-weighted images.  
Hemorrhagic regions are identified on T2*-weighted images with mean signal intensity of  
at least 2 standard deviations (SD) below the reference region [82]. Developing an 
automated segmentation of the hemorrhagic region would be valuable for analyzing the 
temporal evolution of myocardial hemorrhage, and/or other iron-related changes (e.g. due 
to monocyte infiltration post-MI).  
In the present work, we propose an automated segmentation method based on a stabilized 
probability plot, which is a graphical method for assessing whether or not a data set is 
approximately normally distributed [74]. We applied this method to examine the 
distribution of the relaxation rate values in the LV for baseline (non-infarcted) cardiac 
tissue to determine a threshold below which R2* values follow a normal distribution. We 
demonstrate that this method shows potential for future work (perhaps with more advanced 
analysis and shimming) but could not be applied to the post-MI images in the present work. 
Instead we chose a global threshold based on the highest R2* values in baseline images 
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and applied that threshold to segment post-MI images into remote tissue (below threshold) 
and tissue that may be abnormal (above threshold). This baseline study also provides 
insight into the extent and distribution of R2* in the canine LV and illustrates substantial 
regions of high R2* which may be associated with macroscopic magnetic field variations 
(sometimes referred to as susceptibility artifacts). 
 In the model of canine MI that was used in the images that we (retrospectively) analyzed, 
occlusion of the LAD artery typically causes an MI in the LV. While multiple regions of 
the LV may be affected, this type of MI rarely affects the inferior side [83–85]. To provide 
spatial orientation in the context of our analysis, we used polar plots to represent the LV 
based on the 17-segment model developed by the AHA. Also, using a threshold R2* value 
from baseline images, we investigated the change in R2* and volume of “abnormal” tissue 
as a function of time (number of days) post-MI. 
The following three objectives outline the main experimental goals of this study.  
 The first objective was to determine the region with relatively low and uniform R2* 
values by examining the distribution of R2* values within baseline R2* maps of the entire 
LV. To address high R2* values in the LV, we used an automated thresholding algorithm, 
based on an iterative selection method, to identify regions with relatively uniform R2* 
values within baseline R2* maps (i.e. little or no artifacts due to motion, susceptibility). 
We investigated the extent to which the R2* values in this region followed a normal 
distribution. In addition, we compared the mean R2* value of this uniform region with the 
value reported in literature: 0.03-0.050 ms-1 [2, 86, 87]. 
 The second objective was to use the selected region (identified in the first objective) 
in baseline image analysis. For R2* values in this region, we chose a threshold value very 
close to the highest value in the baseline polar plots. This provided a reference point below 
which we considered the post-MI myocardium as healthy.   
 The third objective was to apply the new threshold (objective 2) in the LV post-MI 
and thereby examine changes in R2* associated with changes in tissue iron. With this 
analysis, we studied the changes in R2* and volume of “abnormal” tissue as a function of 
time post-MI. We also studied these changes based on a previously published [88] 
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threshold (R2* > 0.05 ms-1) and compared the resulting time evolutions from these two 
thresholds. 
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Chapter 2: Methods 
2 Background 
The primary cause of MI is a build-up of atherosclerotic plaque in the coronary artery 
(Figure 1.2). A rupture in the plaque forms a thrombus which in turn reduces the flow of 
blood to the muscle, causing ischemia. This creates either a partial or complete decrease in 
oxygen to the muscle depending on that vascular supply, and also necrosis, which is death 
of myocardial cells or tissue [12].  
Severe microvascular injury with or without reperfusion may result in myocardial 
hemorrhage or iron deposition, respectively, and both are associated with left ventricular 
systolic dysfunction [25], a form of adverse remodeling associated with changes in heart 
size and function [26, 27], and poor clinical outcomes [28].  
Cardiovascular magnetic resonance (CMR) imaging has achieved clinical importance in 
the noninvasive evaluation of myocardial viability and function post-MI, allowing for high 
resolution depiction of the infarct size. Visualization of hemorrhage is attributed to the 
degradation of erythrocytes, which leads to iron deposition that can be detected on T2*-
weighted MR images [3, 45]. Along with degradation of red blood cells, hemoglobin is 
broken down into several products (oxyhemoglobin, deoxyhemoglobin, methemoglobin, 
and hemosiderin) which influence MRI signal intensities. The breakdown products of 
hemoglobin are paramagnetic and hence lead to shortening of T2* relaxation times. A 
hypointense core within the infarcted myocardium in T2-and T2*-weighted CMR has been 
correlated with hemorrhagic infarcts [37, 38]. However, a reliable assessment of 
myocardial hemorrhage in T2*-weighted images of the entire LV is challenging due to 
image artifacts, the presence of edema, and manual delineation of the hypointense zone, 
which is prone to observer error. 
Studies have indicated that T2* mapping provides greater accuracy than T2 mapping in 
differentiating between hemorrhagic myocardium and healthy regions remote from the 
injury, and reduces the influence of myocardial edema [53].  Whether examining cells or 
tissue, there is a linear increase in the rate of signal decay (R2* = 1/T2*) as a function of 
iron content [54, 89]. Variations in R2* have also been qualitatively correlated with cardiac 
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iron deposition [2]. In an accepted clinical approach, myocardial hemorrhage is marked as 
a region of reduced signal intensity within the infarcted area on R2* maps, where R2* > 
0.05 ms-1 [38, 53, 62]. However, identifying an appropriate R2* value for healthy 
myocardium would be valuable for analyzing the temporal evolution of myocardial 
hemorrhage, and/or other iron-related changes (e.g. due to monocyte infiltration) post-MI. 
For this purpose, we examined myocardial T2* at 3 T in a canine MI model using T2* 
mapping.  
Many graphical methods such as a histogram or a stem plot can be used to reveal non-
normal features of a distribution, for example, outliers, skewness, and clusters [72]. The 
probability plot is a graphical method for assessing whether or not data exhibit a standard 
normal distribution (i.e. a Gaussian distribution). For a given data distribution, the 
probability plot is created by plotting the actual data against the probability (as a percentile) 
that individual value occupies. The pair points (data, probability) can be fitted to a line that 
is designated as a reference line. If the data is normally distributed, the normal probability 
plot will follow the reference line. Deviation from the straight reference line indicates 
deviation from normality [74]. The point at which R2* (the data) deviates from normality 
provides a threshold above which voxel by voxel analysis of elevated R2* may be spatially 
identified.  
In our analysis, we recorded spatial information using the AHA recommended polar plot 
of the LV [65]. Assembled from tomographic images of the LV, the bull’s eye map has 
been employed for regional analysis of cardiac functions, like wall thickening or 
myocardial perfusion. Moreover, different myocardial segments in the polar plot have been 
assigned to the main coronary arteries (Figure 1.6B), facilitating a comprehensive 
assessment of the cardiac injury. 
The study in this thesis involves a retrospective analysis of canine CMR images as well as 
CMR images from two healthy human adults. The canine data includes images acquired 
following experimentally induced myocardial infarction (permanent occlusion) as well as 
baseline images (i.e., images acquired prior to MI). The animal data had been acquired as 
part of another study and the experimental procedure for inducing MI is described 
elsewhere [90]. The human images were acquired in order to test how changes to the 
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acquisition might influence susceptibility related artifacts. Unless otherwise noted, all GRE 
images were processed using MATLAB 7 R2010b (Mathworks, Nattick, MA, USA) 
 
2.1                Methods 
2.1.1 CMR acquisition of baseline images  
The baseline CMR images that were retrospectively analyzed for this thesis had been 
obtained from six adult female canines studied according to protocols approved by the 
Canadian Council on Animal Care. CMR images were obtained with a Siemens Biograph 
mMR  3 T scanner. Short axis views (10 slices) covering the entire LV utilized a CMR 
multi-echo (8 echoes) GRE T2* sequence (Siemens Work-in-Progress; WIP #44B.1, 
VB20P, Figure 1.5) and were performed with both bright and dark blood imaging 
techniques. Each slice was acquired in one breath-hold. Typical acquisition parameters 
were: bandwidth 925 Hz/pixel; flip angle: 10° for 5 of the canines and 20 ° for one canine; 
matrix size 208x102; spatial resolution 1.4 x 1.4 x 12 mm3; TE: 2-13 ms; slice thickness 6 
mm.  
 
2.1.2 CMR acquisition of post-MI images  
The post-MI images that were retrospectively analyzed for this thesis involved four adult 
female canines studied according to the protocols approved by the Animal Care Committee 
of Western University (Protocol 2011-67). Propofol was used to induce anesthesia and 
controlled with (2%) isoflurane. An MI was produced by putting a snare ligature around 
the LAD for the duration of the study. Animals with this permanent occlusion were imaged 
at 3, 8, 15, 21, and 41 days post-MI. In each animal, CMR images were acquired at 3 T in 
10-13 contiguous short-axis slices covering the entire LV. A multi-echo (8 echoes) GRE 
T2* sequence was performed with a dark blood imaging technique. Typical imaging 
parameters utilized to acquire images were: bandwidth 814 Hz/pixel; flip angle: 20°; FOV: 
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217x290 mm2; matrix size 256x192; spatial resolution 1.4 x 1.3 x 12 mm3; TR: 441 ms; 
TE: 3-23 ms; slice thickness 6 mm.  
 
 
 
2.1.3 CMR acquisition of healthy volunteers  
The goal of involving healthy human adults was to investigate the influence of slice 
thickness on R2* measurements. This study was performed in accordance with a University 
of Western Ontario Health Studies Research Ethics Protocol (Protocol 2011-67). Two 
Volunteers were invited to participate in this study. For each volunteer, informed consent 
was obtained prior to the study.  
CMR images were obtained on a Biograph mMR 3 T scanner (Siemens, Erlangen, 
Germany). Images were collected during breath hold and with ECG synchronization. 
Images were acquired in 3 short-axis slices (apical, mid and basal), utilizing a multi-echo 
(8 echoes) GRE T2* sequence performed using dark and bright blood imaging techniques. 
Typical acquisition parameters were: bandwidth 930 Hz/pixel; flip angle: 10 °, 20 °, and 
30 °; FOV: 340x340 mm2; matrix size 256x256; spatial resolution 1.4 x 1.3 x 12 mm3; TR: 
200 ms; TE: 2-13 ms; slice thicknesses 4 and 6 mm. (The minimum slice thickness 
permitted with this sequence was 4 mm.)  
                                                
2.1.4  Myocardial R2* calculation and R2* map 
construction 
LV contours, including endocardial and epicardial borders were manually drawn using the 
image with the shortest echo time in each slice. The delineation of myocardium was made 
with enough consideration to the separation from tissue intersections to minimize the 
partial volume effect, especially between myocardium and blood. The segmented 
myocardium was represented as a binary image (mask) with ones (1) representing the LV 
myocardium and not a number (NaN) representing elsewhere. The area of the LV 
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myocardium was confirmed on CMR short-axis images by pixel multiplication with the 
corresponding pixel masks.  
Noise on MR signals manifests itself as a Rician distribution in magnitude images [91]. 
MR signal amplitude is affected by the distribution of Rician noise.  When SNR is low, the 
signal must be corrected prior to R2* fitting to compensate for the Rician distribution of 
noise. The corrected  MR signal (S) of T2* decay can be evaluated by [92]: 
                                                         S = √𝑆𝑢𝑛
2 − 2𝜎2    ,                                  (1.9)                                             
where Sun is the magnitude signal value for a given pixel at a given time and σ is the mean 
signal value over a background region of the T2*-weighted images. For this thesis the 
procedure for measuring background involved selecting a 20×20 pixel square in the corner 
of an image (i.e. an area with no CMR signal).  The decay curve obtained was fitted to a 
mono-exponential curve  
                                  
                                      S(t) = S(0)𝑒(𝑅2
∗)(𝑇𝐸)                                   (2.0) ) 
 
Images of the segmented myocardium were processed to generate R2* (1/T2*) maps by 
applying mono-exponential curve fitting to the signal on a pixel by pixel basis.  
 
2.1.5 R2* Precision and Goodness of Fit         
The goodness of fit was evaluated utilizing the coefficient of non-determination (1 – r2) 
defined by 
                                                    1 − 𝑟2 =
𝑆𝐸𝑚𝑜𝑑𝑒𝑙
𝑆𝐸?̅?
                                                               (2.1) 
 
where r is the correlation coefficient,  𝑆𝐸𝑚𝑜𝑑𝑒𝑙 = ∑(𝑦𝑖 − ?̂?)
2 is the total squared error 
between the experimental data (𝑦𝑖) and the predicted value based on the regression model 
(?̂?). 𝑆𝐸?̅? = ∑(𝑦𝑖 − ?̅?)
2 is the total squared error between (𝑦𝑖) and the mean of the (𝑦𝑖)  
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values, and 1 – r2 represents the total variation in the actual data that is not described by 
the model.  
The uncertainty in R2* values was obtained from the 95% confidence intervals provided 
by the Matlab fit function. In particular, we divided this confidence interval by 4 to produce 
a standard error (STE), i.e., ½ of the 68% confidence interval. 
Previously it was suggested that the later echoes should be eliminated from T2* fitting as 
background noise, motion and susceptibility image artifacts in these echoes may affect the 
MRI signals and degrade the R2* analysis [93]. Therefore, we examined the impact of 
number of echoes used in the R2* fitting procedure on uncertainty and goodness of fit. For 
baseline short axis images, STE and 1 – r2 maps were generated for the entire LV with 8, 
6 and 5 echoes.  
 
2.1.6   Fitting MRI signal to region of interest  
In addition to the voxel-by-voxel fitting, the mono-exponential model was applied to a 
region of interest (ROI).  In  baseline images, an ROI covering the interventricular septum 
was chosen to avoid susceptibility artifacts. In  post-MI images, an ROI occupying the non-
normal (potentially injured tissue) R2* region was chosen to illustrate shortening of the 
MR signal.                             
2.1.7 Bulls-eye map construction 
An R2* map was generated for each slice of the entire LV (starting at the most apical slice 
and moving to the most basal slice). For each R2* map, a 4- degree sector rotated around 
the entire slice permitted a radial sampling of the map (Figure 2.1). The center of rotation 
was defined as the center of the LV. The mean value of R2* was determined for each of 
the 90 segments of the myocardium within each slice. This gave 90 R2* values (4o × 90 = 
360o). The process was repeated  for all slices of the entire LV (ending with the basal slice). 
These data were arranged into matrix form, with each row of the matrix consisting of R2* 
values for each sector around the circumference of a given slice. The final matrix formed  
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has the dimension of 90 × number of slices. A Matlab function was used to fill the 
standardized 17-segment model of the LV with the matrix values (Figure 1.6).  
 
 
 
 
 
 
Figure 2. 1. Radial sampling of the myocardial R2* map.  A 4- degree sector (outlined 
in blue) was used to sample the R2* map of a single slice. The sector was rotated counter-
clockwise over the R2* map. Background values were set to equal zero and excluded from 
calculations.   
 
Six polar plots were generated, one for each animal for which baseline data was available. 
These polar plots were then averaged to generate one composite polar plot. To identify the 
uniform region of the composite polar plot with relatively low susceptibility artifact, an 
automated thresholding algorithm, based on an iterative selection method [94]   was used. 
In this method, the half  maximum dynamic range was used as an initial  threshold to 
segment the histogram into two regions. The mean of the samples associated with pixels 
from these two regions were then computed. The average of the two means sampled is 
considered as the new threshold. Based on this new value, the computational process is 
reiterated until the threshold does not change. This segmented area was tested using the 
probability plot to identify the distribution of lower mean R2* values. This area was 
designated as the uniform baseline region and was used to analyze polar plots of post-MI 
images. 
40 
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In this region, the change in the R2* values from each baseline polar plot, is determined by 
the coefficient of variation (CV) as: 
                                                        𝐶𝑉 =
𝑆𝐷
𝑀
                                      (2.2) 
 
 
where SD and M are the standard deviation and the mean value of the R2* measurements, 
respectively.  
 
2.1.8 Probability Plot Method 
 The probability plot is a graphical method to distinguish a deviation from normality. The 
normal probability plot confirms that a hypothesis of normality is reasonable. The data (i.e. 
R2* values) are arranged in ascending order and the normal probability plot is constructed 
by graphing data versus normal order statistic medians (using the equations described in 
section 1.5). The points are fitted to a reference line that represents a theoretical normal 
distribution: the points departing from this line indicate deviations from normality. The 
point at which data start to depart from the straight reference line represents a threshold 
that distinguishes between Gaussian and non-Gaussian distribution (Figure 2.2). 
Mathematical calculations were performed using the Matlab function: probplot 
('normal',data). This method can also show the nature of the departure from normality (e.g., 
skewed data have a short or long tail). 
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Figure 2. 2. Threshold determination technique. Data were tested using the probability 
plot method. Threshold (red arrow) is the point where data deviates from a Gaussian 
distribution, shown by the theoretical straight line (in blue), and provides a value above 
which data deviate from normality.  
 
 
 
 
 
 
 
Threshold 
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2.1.9    Analysis of R2* images 
For baseline polar plots, only the uniform baseline region was considered in the composite 
baseline polar plot, as explained in section 2.1.7. The stabilized probability plot method 
was applied to this area to examine the distribution of  R2* values within this uniform 
baseline region. We determined the critical point (visually) where the distribution of R2* 
values change from a normal to non-normal distribution.  
The motivation for using the probability plot method on baseline images was to determine 
if it could be used for post-MI differentiation of abnormal versus normal tissue.  However, 
our results showed that while the method has potential for future application, on these 
baseline images it led to the selection of relatively large regions as being “abnormal”. 
Hence we chose not to utilize this method for post-MI analysis. Instead, we determined a 
general threshold as follows. For each of the six polar plots, we determined the 95th 
percentile of R2* values. The highest of these six values was used as a threshold for post-
MI analysis. 
For post-MI images, the threshold value was applied within the region that was found to 
be uniform on baseline images. The rationale for this was that we assumed that this region 
of the LV would have minimal susceptibility-related contributions to R2*. In the post-MI 
polar plots, the threshold was applied to segment the LV into high R2* region (considered 
as “abnormal”) and low R2* region (normal). The mean R2* values of abnormal R2* 
regions were calculated over time post-MI. We also determined the volume of tissue, 
relative to the volume of the uniform baseline region, with R2* values above the proposed 
threshold. This measure will be referred to as the percentage of ROI volume with high R2* 
(%LV). The results were compared with the common threshold (R2* >  0.05 ms-1) [34].  
2.1.10  Statistical analysis 
To examine possible alterations in the mean R2* values over five-time points post-MI, we 
compared the values using repeated measure ANOVA at α = 0.05 (IBM SPSS Statistics, 
version 25)  for each of the three conditions ( R2* > 0.05 ms-1, R2* > 0.08 ms-1, and R2* 
< 0.08 ms-1 (remote tissue)). To this end, we compared alterations in threshold values 
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within each threshold (0.05 ms-1 and 0.08 ms-1) at time points of 3, 7, 15, 21 and 41 days 
post-MI. In addition we comapred threshold values of 0.05 ms-1 and 0.08 ms-1 at the same 
time points. Using a mixed model ANOVA, we compared %LV between two thresholds  
(0.08 ms-1 vs 0.05 ms-1) at  time points of  3, 7, 15, 21 and 41 days post-MI.  
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Chapter 3: Results 
3 Results 
3.1 The signal decay model 
Figure 3.1 illustrates the mono-exponential decay model applied to a multi-gradient echo 
signal from a ROI covering the mid-ventricular septum of a representative baseline image. 
The mean R2* value in the interventricular septum for 3 slices (apical, middle and basal) 
was 0.050 ± 0.005 ms-1. R2* values, based on ROI exponential fitting were measured in   3 
dogs.  
 
 
 
 
 
 
 
 
Figure 3. 1. A mono-exponential decay model. The left-hand panel shows a baseline 
T2*- weighted image of the LV with an ROI outlined in red within the mid-ventricular 
septum. The right-hand panel shows a plot of signal intensity at each TE acquired (2-19 
ms). The mono-exponential curve was fitted to derive the R2* (1/T2*) value.  
 
 
3.2 Effect of number of images on R2* measurements  
Figure 3.2 illustrates representative baseline polar plots of R2*, STE and 1 ‒ r2 obtained 
from one dog using either all 8 echoes or only with the first 5 or the first 6 echoes for the 
fitting procedure. Visual inspection of the polar plots shows that reducing the number of 
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echoes did not reduce the spatial variation of R2*. In addition, higher STE and 1 ‒ r2 values 
were obtained with fewer echo numbers, indicating greater variability in R2* upon 
omission of data collected at later TE. Table 1 shows the mean values for R2*, STE and 1 
‒ r2 over 3 subjects. These data suggest that all eight echoes should be used for further 
analysis. Additional results are in Appendix (A).  
 
 
Figure 3. 2. The influence of number of echoes on R2*, STE, and 1 ‒ r2 maps. The 
upper row shows R2* maps, the middle row shows STE maps and the lower row shows 1 
‒ r2 maps, for baseline polar plots of the entire LV of one dog using, 8, 6 and 5 echoes. 
There was no significant variation in R2* polar plots with fewer echoes (upper row). 
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Higher STE (middle row) and 1 ‒ r2  (lower row) values were obtained by excluding later 
echoes. 
Table 1. Mean R2*, STE and 1 ‒ r2 for the entire LV relative to the number of echoes 
/ slice used for  generating R2* maps.  
 
 
 
* Mean refers to the average over all sectors and over 3 dogs. 
3.3 Healthy volunteer R2* measurements  
Data from two male healthy volunteers (age range = 28 to 42) with no history of MI was 
acquired in order to determine if R2* would be reduced by reducing slice thickness, thereby 
suggesting that macroscopic magnetic field spatial variation contributes to R2*. A 
comparison between 6 mm and 4 mm thick slices at the levels of apex, middle and base of 
the LV with both bright and black blood imaging is shown in Table 2. This data shows 
larger mean R2* values with 6 mm vs. 4 mm slice thickness. By these ﬁndings, the black-
blood sequence with thinner slice thickness improves R2* measurements. 
Table 2. Mean R2* values for different slice thicknesses, standard deviation (SD) and 
difference  in R2* between 6 mm and 4 mm slice thickness values. 
 
 * Data obtained from 2 volunteers 
Number of 
echoes 
Mean R2* 
(ms-1) 
Mean STE Mean 1 ‒ r2 
8 0.046 ± 0.020 0.015 0.15 
6 0.048 ± 0.025 0.020 0.20 
5 0.044 ± 0.026 0.026 0.25 
              Bright Blood                Dark Blood 
              Slice thickness               Slice thickness 
 Volunteer 4 
mm  
6 mm Difference 4 mm  6 
mm 
Difference 
Apex Volunteer1 0.030 0.047 0.017 0.040 0.047 0.007 
 Volunteer2 0.040 0.045 0.005 0.041 0.045 0.004 
Mid Volunteer1 0.046 0.057 0.011 0.037 0.042 0.005 
 Volunteer2 0.041 0.052 0.011 0.041 0.047 0.006 
Base Volunteer1 0.047 0.052 0.005 0.047 0.057 0.010 
 Volunteer2 0.040 0.045 0.005 0.046 0.053 0.007 
Mean 
+/- SD  
   0.010 ± 
0.004 
  0.006 ± 
0.002 
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3.4 Spatial variation of R2* at baseline 
Polar plots of R2* maps at baseline demonstrate the variation in R2* values through the 
entire LV (Figure 3.3). We noted a substantial degree of heterogeneity in the inferior-septal 
region (segments 3, 4, 9, 10, 14, 15 and 17) of baseline plots, suggesting that macroscopic 
magnetic field variations may be large in these segments. Additional results are in appendix 
(B and C). 
 
 
 
 
Figure 3. 3. Baseline R2* relaxation rates. Polar plots represent the 17 segments of the 
basal (outer ring), mid-ventricular (middle ring) and apical (central ring) short-axis planes 
of the LV from each canine subject (A-F). For these baseline R2* maps, data in A and B 
were generated with a bright blood sequence and flip angle of 100. Data in C-F were 
generated with a black blood sequence and flip angle of 100, with the exception of D, where 
flip angle was 200. 
ms-1 
(A) (B) (C) 
(D) (E) (F) 
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3.5 R2* segmental analysis at baseline 
Polar plots from the six baseline images (Figure 3.3) were averaged, resulting in one 
composite R2* polar plot (Figure 3.4A). The mean R2* ± SD value in all subjects was 
0.048 ± 0.015 ms-1. Figure 3.4B illustrates the segmental analysis of the composite polar 
plot. The inferior-septal region represented by segments 3, 4, 9, 10, 14, 15 and 17 showed 
higher spatial variation compared to the remaining segments. This indicates that the 
inferior-septal zone is affected by artifacts (likely susceptibility-related) more than the 
lateral, anterior, and septal zones. The mean values of inferior-septal and unaffected zones 
are significantly different: 0.06 ± 0.01 ms-1 versus 0.041± 0.02, respectively, p<0.001. 
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Figure 3. 4. Segmental analysis of the composite baseline polar plot for R2*. A) The 
polar plot shows the average polar plot over all animals (n = 6), providing a standardized 
baseline for the entire LV. B) Segmental analysis shows the variation in mean R2* values 
across the entire LV based on the 17-segmental model. The analysis indicates that the 
inferior septal region represented by segments 3, 4, 9, 10, 14, 15 and 17 has higher mean 
R2* values compared to the overall mean value (0.042 ± 0.007ms-1) for the baseline 
myocardium. The vertical bar represents SD for mean R2* in each segment.  
 
Figure 3.5A and B illustrate the region (in red) within the composite baseline R2* polar 
plot that is spatially relatively uniform, based on the application of an iterative selection 
algorithm (refer to section 2.1.7). This is taken to be a region with minimal susceptibility-
related artifact due to macroscopic magnetic field variations. Figure 3.5B shows that the 
distribution of R2* values in the region outlined in red follows an approximately normal 
distribution based on the probability plot test. This region will be used for post-MI analysis 
(the uniform baseline region). Since the inferior-septal region has very high R2* values at 
baseline (possibly from susceptibility related contributions to R2*), it was excluded from 
the analysis of post-MI images. 
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Figure 3. 5. R2* distribution in the region of the LV denoted as a baseline signal. A) 
The baseline region (ROI outlined in red) was selected based on B) an iterative selection 
method. C) The selected baseline ROI was interrogated using the Probability plot test and 
shows an approximately normal distribution of R2* values. 
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Figure 3.6 provides an analysis of the distribution of R2* values within the same uniform 
baseline region in individual subjects (C and F). There was a substantive deviation from 
normality in four dogs ( see Appendix D). This  variations on R2* distribution might be 
due to the large slice thickness (6 mm).  
  
 
 
 
 
 
 
 
 
 
 
Figure 3. 6. Baseline R2* relaxation rates and their distribution. The upper row shows 
polar plots of R2*maps covering the entire LV of two dogs (C and F). The lower row shows 
the distribution of R2* values within the uniform baseline region for these two polar plots. 
R2* values follow an approximately normal distribution on the left plot but deviate 
substantially from normality on the right.   
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Table 3 provides values of the % CV and the 95th percentile of R2* values for each of the 
six baseline polar plots within the same uniform baseline region (Figure 3.5A). The SNR 
was higher in dog D compared to other dogs. The baseline T2*-weighted images for this 
dog were acquired with flip angle 200, where T2*-weighted images for the remaining 
subjects were obtained with flip angle 100. 
The highest of these (0.08 ms-1) was used as the threshold for differentiating normal R2* 
regions from abnormally high R2* regions in post-MI polar plots.   
 
Table 3. Comparison of baseline %CV and thresholds based on the 95 percentile  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.6 Signal decay model for post-MI images  
Figure 3.7A shows a representative short axis view of the LV 3 days post-MI with 8 TE 
values (3-23 ms) demonstrating the T2* signal decay. Figure 3.7B illustrates decay of the 
ROI signal as a function of echo time.  The signal deviates from the exponential curve 
fitting at late echo times. 
Dog %CV 95 percentile (ms-1) 
A 36 0.06 
B 40 0.08 
C 55 0.05 
D 22 0.05 
E 36 0.07 
F 45 0.06 
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Figure 3.7. Pattern of signal intensity decay post-MI. (A) Panels show the series of 
short-axis T2*-weighted images of the LV, acquired at 8 echo times.  The ROI was selected 
to cover the core of injury (red). (B)  The mono-exponential curve is the best fit for signal 
intensity (SI) versus TE in the uniform baseline region. 
(B)
(A)
TE=      3.4               6.2                 8.9                 11.8           14.6               17.5            20.3             23.1         ms                 
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3.7 R2* Analysis for images post-MI 
Guided by the baseline analysis, which showed a relatively uniform R2* signal in the 
lateral, anterior, and septal sectors of the LV (Figure 3.5A), we applied this uniform 
baseline region to each polar plot obtained post-MI (see appendix E). 
In a representative animal at 3 days post-MI, Figure 3.8 shows the R2* maps for each 
short-axis slice of the entire LV. The respective polar plot (below) identifies regions with  
non-normal R2*. 
 
 
 
 
 
 
 
 
 
 
Figure 3. 8. R2* maps of the entire LV post-MI.  At day 3 post-MI, ten R2* maps display 
short-axis slices related to apical, middle, and basal regions of the LV (top) and their 
corresponding polar plot (bottom). The uniform baseline region is outlined in red, 
permitting assessment of regions with a non-normal R2* distribution relative to the 
baseline LV. 
 
 
 
0.2 
0.18 
0.16 
0.14 
0.12 
0.10 
0.08 
0.06 
0.04 
0.02 
0 
ms-1 
46 
 
Figure3.9A shows the abnormally high R2* within the uniform baseline region and Figure 
3.9B  shows the segmented  abnormally high R2* region based our threshold (R2* > 0.08 
ms-1).  
 
 
 
 
 
 
 
 
Figure 3. 9. Automatic delineation of the abnormally high R2* region. A) The polar 
plot of the entire LV at 3 days post-MI excludes the inferior region (blue mask) with 
relatively high susceptibility artifacts. B) After applying the threshold method, abnormally 
high R2* regions (in red) are identified based on our threshold. 
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Figure 3.10 shows the abnormally high R2* based on the literature threshold and our 
threshold (0.05 ms-1 vs. 0.08 ms-1), respectively. Additional results are in Appendix (E). 
 
 
 
 
 
 
 
 
 
Figure 3. 10. Comparison of the abnormally high R2* region based on the reported 
and proposed thresholds.  The abnormal R2* regions (in red) in the polar plot of the entire 
LV at 3 days post-MI are identified based on A) a threshold of 0.05 ms-1 from the literature 
and B) a threshold of 0.08 ms-1 from our analysis of baseline images. 
Changes with time in the mean R2* were significant for day 3 vs. day 41 (p <0.05) for 
the region with R2* > 0.08 ms-1 but not significant for the region  with R2* > 0.05 ms-1 
or for the remote region (Figure 3.11 A). The remote R2* values do not appear to deviate 
from the baseline value (shown on the vertical axis in Figure 3.11). When we compared 
R2* values at each time point in the threshold of 0.08 ms-1 vs. the corresponding time 
point in the remote region, there were significant differences (with different levels of 
significance) between them. 
Figure 3.11 B shows the combined evolution of abnormally high R2* regions post-MI. 
%LV obtained with R2* > 0.05 decreased from 11% at day 3 to 3% at day 41. However, 
the %LV obtained with the previously reported threshold (R2* > 0.05) indicates 22-42% 
(A) (B) 
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involvement of the ROI volume. When we compared %LV at each time point in 
threshold of 0.08 ms-1 vs. the corresponding time point in the threshold of 0.05 ms-1, there 
were significant differences (with different levels of significance) between them. 
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Figure 3. 11. Analysis of the abnormally high R2* region post-MI. A) Mean R2* values 
for abnormal regions of myocardium are shown using two different thresholds: 0.05 ms-1 
(black) and 0.08 ms-1 (red), with each mean compared to mean R2* values for remote 
(normal, unaffected) myocardium (green), averaged over all animals. The two * indicate a 
significant difference in mean R2* (p < 0.05) at day 3 and at day 41 using the 0.08 ms-1 
threshold and using the 0.05 ms-1 threshold. In addition, there were significant differences 
between the 0.08 ms-1 threshold and remote R2* mean values at all data-collection points, 
including post-MI day 3 (p < 0.001), day 8 (p < 0.001), day 15 (p < 0.05), day 21 (p < 0.05) 
and day 41 (p < 0.05). B) The evolving volume of abnormal cardiac tissue (%LV) is 
graphed over time, post-MI, using the two thresholds: 0.05 ms-1 (black) and 0.08 ms-1 (red). 
Depicted are means +/- standard errors for n = 4 dogs. Significant differences between the 
two thresholds were noted at all data-collection points by mixed model ANOVA (α =0.05):  
* p < 0.05; ** p < 0.01; *** p < 0.001. 
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Chapter 4: Discussion, Summary and Future Work 
4 Discussion  
In CMR imaging, R2* measurements are typically used to identify the presence of 
hemorrhage. However, various artifacts from different sources can alter the R2* 
distribution and skew the correspondence between R2* values and  noninvasive assessment 
of the disease process.. 
Several experimental factors complicate the application of R2* measurements for detecting 
post-MI changes like hemorrhage. For example, partial volume effects [95, 96], magnetic 
susceptibility artifacts, low SNR and motion  artifacts can influence R2* measurements. 
Also, the signal decay curve may be restricted from reaching baseline by blood pool and 
motion artifacts. All these factors can influence calculation of the R2* value. 
In studies of iron thalassemia patients, Pennell [93] and Anderson et al. [2] indicated that 
the later TE signals could be buried in blood artifacts and background noise. To address 
this problem, Westwood et al. [97] and Tanner et al. [98], also in iron thalassemia studies, 
adopted a truncation approach in which the images at later TE are subjectively excluded 
and the remaining signal is ﬁtted with a simple monoexponential model. Importantly, all 
of these proposed techniques were based on bright-blood T2* acquisition and ROI-based 
analysis. However, Baksi et al. [99] and He et al. [100] have shown that when using a dark-
blood sequence, the myocardial border is defined clearly and the MRI signals can be 
properly fitted against all TE values by a monoexponential model. 
In pixel-wise technique, R2* measurements are more challenging compared to ROI-based 
analysis due to low SNR. In a previous report involving black blood T2* mapping in a 
canine model [101], only images from the first five echoes were included in the fit and it 
was suggested that this would reduce the impact of motion artifacts.  However, in our study 
excluding the last 2 or 3 echoes in black-blood baseline images did not reduce the fit 
uncertainty in pixel-wise R2* values (Figure 3.2). Our results indicate that using images 
from all TE values achieved the lowest standard error in R2* and lowest values of 1 - r2. 
In addition, any changes in the mean R2* values with number of echoes was small. (Table 
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1). One would expect that under ideal conditions (e.g., no motion artifacts, no 
contamination from the blood signal) more TE points should provide more precise R2* 
measurements.  
Port and Pomper [102] found that susceptibility artifacts on gradient echo images were 
moderately reduced with decreasing slice thickness (from 6 mm to 3 mm). This ﬁnding ﬁts 
with our results for healthy human analysis (Table 2). For better visualization of MI, 
Simonetti et al. [103] indicated that the ideal flip angle for  inversion-recovery GRE 
cardiac imaging is 200. We found lower %CV in one baseline image with a 200  flip angle 
compared to others with a 100 flip angle.  
A qualitative study of pig hearts showed that the heart-lung interface or air pockets close 
to the heart (from the stomach, for example) may potentially cause signal artifacts in T2*-
weighted MRI and are distributed radially from the interface [81, 104]. These so-called 
magnetic susceptibility artifacts are associated with  signal loss in T2*-weighted images 
and therefore increase R2* values. The variations in diamagnetism (e.g., tissue versus air)  
lead to distortion of the applied magnetic field especially at the interface between tissues 
(i.e., heart-lung). This field distortion can cause magnetic susceptibility artifacts and  affect 
the distribution of R2* values. Figure 3.3 illustrates the spatial variation in R2* over the 
entire LV for six dogs in the baseline condition (no MI). It is likely that the high R2* values 
(red, yellow), which are largely in the inferior septal region are due to magnetic 
susceptibility-related effects. We expected the variation in R2* values would be highest in 
the lateral zone due to the susceptibility artifacts produced at the heart-lung interface [81]. 
But instead, there was low variation in R2* values in this area compared to the inferior-
septal region. This result may be due to susceptibility artifacts from air pockets, cardiac 
veins, or  the  posterior interventricular branch of the right coronary artery, which could 
decrease the MR signal detection [104].  
The  purpose of averaging the six polar plots into one composite polar plot was to identify 
the regions with relatively low susceptibility artifacts (Figure 3.4 A). The segmental 
analysis showed variations in R2* values across the LV segments  (Figure 3.4 B).  R2* 
variation was at a minimum in the anterior-septal zone. The inferior-septal segments were 
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mostly affected by susceptibility artifacts. The mean R2* value within the uniform baseline 
region (with expected low susceptibility artifacts) was 0.042 ±0.01 ms-1, in agreement with 
the literature [2, 86].  The analysis of the composite polar plot using an iterative selection 
method (Figure 3.5 A) confirms our observation and segmental analysis, showing that the 
inferior-septal region is mostly affected by susceptibility artifacts. The distribution of R2* 
values within the region of relatively low susceptibility artifacts on the cumulative polar 
plot was approximately normally distributed based on the probability test (Figure 3.5 C), 
consistent with the results of Kadir et al. in 12 patients post-MI [105].  
In studies of post-MI T2* imaging, the remote region is located distant from where the 
infarction injury is believed to be (visually) and away from cardiac veins, so as to avoid 
susceptibility artifacts [106]. One common approach (R2* > 0.05 ms-1) is based on using 
the remote region as a reference. In another approach, Kali et al.[3] and Bulluck et al. [107]  
defined the hemorrhagic region as the location where the signal intensity on T2*-weighted 
images is at least 2 SD below a reference region of interest (remote myocardium). They 
showed that hemorrhagic R2* values range between 0.06-0.07 ms-1.  However, with this 
manual approach two observers are commonly employed to assess inter-observer 
correspondence and the analysis of multiple-slices over several subjects can be time 
consuming. Also, image gray level variations, due to variation in B1 and signal detection, 
make it difficult to use this method over a large region (e.g, whole LV). In addition, Ghugre 
et al., in a porcine MI-model [63], indicated that the process of LV remodeling post-MI is 
complicated, with different mechanisms happening concurrently and potentially leading to 
signal changes in the remote region. Therefore, they suggested that the remote region may 
not be the recommended choice for reference tissue in MI. 
 To select the appropriate threshold for detecting abnormal tissue on post-MI images (Table 
3), there is a trade-off between underestimating and overestimating the extent of abnormal 
tissue, where the latter involves including regions with high R2* values due to 
susceptibility artifacts.  The appropriate threshold depends on the MI, the responses post-
MI and where the threshold is going to be used. Choosing a higher threshold that results in 
a low fraction of higher R2* might be a reasonable selection. We have suggested a new 
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threshold at 3T to estimate the extent of  elevated R2* (e.g. hemorrhagic region) post-MI 
based on the analysis of the distribution of R2* values on baseline images.  
 
In this thesis we considered a novel method for potentially distinguishing normal from 
abnormal cardiac tissue post-MI. The proposed idea was to use the probability plot 
procedure to determine a threshold for each post-MI polar plot based on the R2* value at 
which the data begins to deviate from normality. However, we had to first test this on 
baseline images to ensure that the area considered to be “abnormal” on these images would 
be very small. Firstly, we applied an iterative selection algorithm to determine a relatively 
uniform region within the cumulative baseline R2* polar plot. Within this region, we found 
that the distribution of R2* values followed an approximately normal distribution based on 
visual inspection of the probability plot. This was an encouraging result. However, when 
the probability plot was applied to individual baseline subjects, we found that the 
distributions for most subjects deviated from normality (Figure 3.6 and Appendix D).  For 
that reason we were unable to apply this novel method to our post-MI data. However, the 
finding of approximate normality in the cumulative baseline polar plot suggests that it 
might be possible to further explore this method in the future. In particular, we could 
determine if improvements to acquisition (e.g., improved shimming) or analysis (other 
fitting, automated or improved delineation of the myocardium) could improve normality 
of the R2* distribution in baseline images. 
The value of the threshold (R2* > 0.08 ms-1)  proposed in this thesis work is in reasonable 
agreement when compared to the previously reported threshold value (R2* > 0.05 ms-1) for 
differentiating “normal” from “abnormal” R2* values. However, as shown in Figure 3.9 
and Appendix F, the volume of tissue classified as abnormal was substantially smaller with 
a threshold of 0.08 ms-1 compared to 0.05 ms-1. Also, the latter threshold (0.05 ms-1) leads 
to disconnected abnormal regions (Figure 3.10). Although the reported threshold provides 
a potential to differentiate between remote and hemorrhagic regions post-MI, there are  
factors that can cause variation in MRI signals over time points post-MI. For example, 
hemoglobin byproducts  can vary during the healing process. In this regard, Ghugre et al. 
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[63] in a porcine MI model have characterized the form of hemorrhage between day 2 and 
day 15 post-MI, identifying erythrocytes (containing ferrous iron) as the predominant 
species at early times post-MI and iron-rich macrophages (with ferric iron) as the 
predominant species at later times post-MI. Also, the amount of iron present in tissue may 
be cleared by macrophages through time post-MI. 
Several studies have shown that R2* values rose from baseline, and peaked 2 days post-
MI followed by a decrease over time post-MI [26, 49, 108]. Ghugre et al.[63] in a porcine 
MI model showed that higher values of  R2* post-MI agreed with the presence of both 
mineralization and hemorrhage, making it a potential marker for those histological 
characteristics. Moreover, R2* values post-MI did not return to the baseline range, 
suggesting that elevated R2* may also be associated with the resolution of inflammation 
and MVO. 
In this thesis, the mean values of elevated R2* within the uniform baseline region based on 
the two thresholds (R2* > 0.08 ms-1 and the reported value of R2* > 0.05 ms-1) are 
compared to remote myocardium averaged over all (n=4) animals (Figure 3.11 A). The 
mean values of high R2* regions were significantly higher than the mean of remote regions 
(p < 0.05). In addition, the remote regions remained close to the mean R2* of baseline 
tissue (0.04-0.05 ms-1), consistent with the literature [2, 86]. The evolution of regions with 
high R2* showed an increase at day 3 relative to the mean baseline value 0.042±0.01 ms-1 
at day 0, and showed a decrease by day 41 but not a return to remote levels. This might be 
due to a change in the form of iron, resulting in a change in the magnetic properties [109], 
or this might be an indication of the degree of iron deposition present in the myocardium 
[2, 110]. The %LV obtained with an R2* threshold of 0.05 ms-1 ranged between 22-42%; 
whereas, the 95th percentile with threshold of 0.08 ms-1 ranged from 3-11%  involvement 
of the ROI volume (Figures 3.11 B).  
The time needed for myocardial hemorrhage (one form of high R2*) to resolve is still 
unclear. Carrick et al. [53] studied the time course of both hemorrhage and MVO in patients 
and demonstrated that hemorrhage only occurred within regions of MVO. The amount of 
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myocardial hemorrhage was reduced over time post-MI. Robbers et al. [43] showed that 
hemorrhage is a consequence of MVO. 
The thesis study has some limitations. First, susceptibility artifacts affect the determination 
of injury and/or iron in tissue. Our work provides an approximate threshold (0.08 ms-1) to 
differentiate abnormal (potentially hemorrhagic) tissue, but is based on only six baseline 
images. Post-MI high R2* values due to susceptibility artifacts could potentially be above 
this threshold. Second, analysis of the pathophysiology (e.g., mineralization, tissue iron 
levels) and cardiac measures (e.g., ejection fraction) are required to better understand the 
consequences of the time course and spatially dependent variation in R2* values post-MI. 
Third, although previous studies have shown an approximately linear relationship between 
R2* and  tissue iron deposition, other studies indicated that a limited dynamic range for 
R2* measurements could influence the relationship between measured R2* and iron 
content [111, 112]. Since the inter-echo time for the first two echoes in our study is 
approximately 3 ms, we estimate that the highest R2* that could be measured (i.e., the top 
of the dynamic range) is on the order of (1/3) ms-1.  High variations in R2* values could be 
reduced by increasing the sample size, a limitation of the current study, and would be 
considered in the next cohort study.  
 
 
 
 
 
 
 
56 
 
4.1 Summary 
R2* mapping procedures are more specific in providing regional and cross-subject 
comparisons compared to signal intensity measures in individual images.  The main goals 
of this thesis were to assess the R2* signal obtained from cardiac MRI, before and after 
myocardial infarction in canine subjects. R2* measures are relevant since hemorrhage can 
be recognized in the presence of other post-MI responses such as edema. 
Using all 8 echoes in fitting baseline images led to better goodness of fit and reduced 
uncertainty compared to using only 5 or 6 echoes and did not lead to substantially different 
mean R2* over the entire LV. From our assessment of baseline images using polar plots, 
we found regions of high R2* in the inferior-septal segments of the LV. This is in good 
agreement with the findings of Sorrel et al. (2004)  who showed that the presence of 
susceptibility artifacts in the inferior-septal regions are due to air pockets in adjacent 
organs, intestine or stomach [104]. Using images from two human volunteers we found 
that reducing slice thickness led to reduced mean R2* (i.e., thinner slices are better where 
possible). By using an iterative selection algorithm on a cumulative baseline image, we 
found a large region (approximately 75% of the LV) with relatively low and uniform R2*. 
Importantly, the probability plot method showed that the distribution of R2* values in the 
cumulative polar plot was reasonably close to a normal distribution on visual inspection. 
However, this normality did not hold for most individual baseline images. Taken together, 
differences between a cumulative analysis compared to individual analysis, indicate that 
use of the probability plot for determining thresholds to separate abnormal from healthy 
tissue post-MI may have potential in the future, but for the present data would likely include 
(very large) regions of “healthy tissue”. We used baseline images to determine a threshold 
corresponding to the highest percentile (95th) of R2* values for all baseline images. This 
threshold value (0.08 ms-1) was higher than that previously reported (0.05 ms-1). 
We used the large LV region that was found to be relatively uniform on baseline images 
and both threshold values (0.08 ms-1 and 0.05 ms-1) to segment high (“abnormal”) R2* 
regions in post-MI images that had been acquired at several times points (3 to 41 days) post 
MI. We found much smaller high R2* regions with threshold of 0.08 ms-1 compared to 0.05 
ms-1. Using the higher threshold, we found that higher R2* values were present in the 
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inferior-septal and the anterior-lateral regions of the LV.  This finding is in agreement with 
Ghugre et al. [63] and Kali et al. [3] who showed higher R2* values in post-MI images of  
the anterior-lateral region due to LAD occlusion. However, our findings on high R2* 
values in the inferior-septal region is not consistent with other human and animal studies 
[83–85]; this discrepancy could be due to either susceptibility artifacts or LAD occlusion. 
We found that mean R2* values of remote tissue regions remained in the range of  the 
mean R2* of baseline tissue, which is consistent with previous reports [2, 86, 87]. In 
addition, evolution of R2* post-MI showed an increase at day 3 relative to the mean 
baseline value and a decrease on day 41 but did not return to baseline levels. As well, the 
percentage of abnormal tissue within the uniform baseline region of the LV (%LV) reached 
a maximum level at day 3 and generally decreased by day 41.  
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4.2 Future Work 
One of the major challenges of R2* mapping involves the contribution of macroscopic 
magnetic field variations to R2* often due to interfaces between regions of different 
magnetic susceptibility (sometimes called susceptibility artifacts). We found that this was 
a major contribution to R2* in baseline images (inferior-septal region of LV). There are 
several methods that could potentially reduce the contribution of susceptibility artifacts to 
R2*. For example, improved shimming of the heart [113] may be considered. In addition, 
reducing slice thickness reduces the susceptibility contribution [114], but also reduces the 
signal to noise ratio and would increase the number of breath holds required. To reduce the 
number of breath holds, perhaps increasing parallel imaging acceleration would be helpful, 
again at expense of SNR. An improved multi-channel RF coil could potentially be of 
benefit to increase SNR. Post-processing methods could also be helpful to reduce 
susceptibility artifact contribution. For example, a more complex fit model that includes a 
Gaussian-like component as well as an exponential-like component could be used but 
requires good SNR. We have performed preliminary experiments with this approach, but 
it failed possibly due to inadequate SNR. In the future, we could filter images first before 
attempting this fitting procedure. Also, phase maps (from the same sequence) could 
possibly be used to help correct for susceptibility contributions. Reducing the contribution 
from susceptibility artifacts may also improve the possibility of using the probability plot 
analysis.  
A reliable and accurate segmentation method for the LV wall boundary would be valuable. 
This might enhance the potential of the probability plot thresholding method to produce 
precise quantification of hemorrhagic cores in the entire LV, decrease the user involvement 
and improve the time required for image analysis to be performed. 
It is also important to incorporate R2* mapping (i.e. high R2* regions) with 2D or 3D late 
gadolinium images in order to assess the hemorrhage location with respect to 
microvascular obstruction. This would require image registration between the two-
dimensional multislice T2*-weighted images and 3D gadolinium-enhanced images. 
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It may also be beneficial to correlate the appearance of a hypointense zone on other 
relaxation parameters such as the T1 and T2 maps with R2* maps to define the region of 
myocardial hemorrhage [107]. In addition,  hybrid imaging (PET/MRI) may give metabolic 
information about myocardial tissue that can establish the best strategy for myocardial 
hemorrhage evaluation and illustrate its temporal evolution [115]. Furthermore, variations 
in functional cardiac measures (i.e., ejection fraction) provide important information 
regarding infarct size [116], which in turn determines the degree of myocardial hemorrhage 
[45]. Finally, histopathologic images are necessary to localize the hemorrhagic core within 
the infarcted region and iron deposition within the hemorrhagic zone [117]. 
The human heart is similar to the canine heart in structure and equivalent in function. 
However, in any model, susceptibility artifacts should be minimized, for example, using 
thinner slice thickness or improving heart shimming. The R2* thresholding approach can 
be translated to human MI studies by showing the relation between R2* threshold and 
impaired ventricular functions (i.e., ejection fraction). 
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4.3 Conclusion:  
In this thesis, we found that R2* maps of the LV of canine subjects that had not been 
exposed to heart injury (baseline) showed a region of very high R2* values, likely 
associated with magnetic susceptibility artifact, in the inferior-septal region of the LV. 
Eliminating latter echoes in the fitting procedure did not reduce this artifact and led to 
reduced goodness of fit and increased fit uncertainty for R2*. However, based on our 
studies on human subjects we found reduced mean R2* with thinner slices (4 mm vs 6 
mm) suggesting reduced susceptibility artifact.     
In addressing our first objective, we found a large LV region on baseline images that had 
relatively low and uniform R2*. From the analysis of this region as proposed in our second 
objective, we determined that a threshold R2* value of approximately 0.08 ms-1 would be 
reasonable for separating normal from “abnormal” tissue post-MI, within this spatial 
location. This threshold is higher than that (0.05 ms-1) previously reported in animal and 
clinical studies. By considering this selected region on the post-MI polar plots, as per our 
third objective, we found that segmented volumes of “abnormal” tissue with our threshold 
were much smaller than regions segmented with the previously reported threshold. Mean 
R2* values of remote tissue regions remained in the range of the mean R2* of baseline 
tissue. Also, the mean values of high R2* regions were significantly higher than the mean 
of remote regions (p < 0.05) over time post-MI. In addition, the %LV with our R2* 
threshold 0.08 ms-1 ranged between 3-11%.  
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Appendix 
Appendix A:  on R2*, STE, and 1 ‒ r2 maps, for baseline polar plots of the entire LV using, 8, 6 
and 5 echoes / slice, respectively. 
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Appendix B: R2*, STE, and 1 ‒ r2 maps, for baseline polar plots of the entire LV of 6 dogs 
using, 8/ slice 
79 
 
Appendix C: Ten R2* maps display short-axis slices related to apical, middle, and basal regions 
of the LV (right panel) and their corresponding polar plot (left panel).  
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Appendix D: The distribution of R2* values within the same the uniform baseline region in six 
subjects  
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Appendix E: Polar plots represent the 17 segments of the basal, mid-ventricular and apical short-
axis planes of the LV from 4 dogs, at several time-points post-MI (3,8,15,21, and 41 days) 
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Appendix F: The non-normal R2* regions (in red) in the polar plot of the entire LV at 
3,7,21, and 41 days post-MI are identified based on 0.05 and 0.08 ms-1 thresholds for 
dogs 1-4 (in order). 
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